Nezam Afdhal
Nezam Afdhal
Professor of Medicine, Harvard Medical School
Adresse e-mail validée de
Citée par
Citée par
Liver cirrhosis
D Schuppan, NH Afdhal
The Lancet 371 (9615), 838-851, 2008
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...
New England Journal of Medicine 370 (20), 1889-1898, 2014
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
P Marcellin, E Gane, M Buti, N Afdhal, W Sievert, IM Jacobson, ...
The Lancet 381 (9865), 468-475, 2013
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ...
New England Journal of Medicine 370 (16), 1483-1493, 2014
Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection
GR Foster, N Afdhal, SK Roberts, N Bräu, EJ Gane, S Pianko, E Lawitz, ...
New England Journal of Medicine 373 (27), 2608-2617, 2015
Response-guided telaprevir combination treatment for hepatitis C virus infection
KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ...
New England Journal of Medicine 365 (11), 1014-1024, 2011
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
European Association for the Study of the Liver
Journal of hepatology 63 (1), 237-264, 2015
Evaluation of liver fibrosis: a concise review
NH Afdhal, D Nunes
Official journal of the American College of Gastroenterology| ACG 99 (6 …, 2004
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ...
Gastroenterology 139 (1), 120-129. e18, 2010
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...
Gastroenterology 149 (3), 649-659, 2015
Telaprevir for previously treated chronic HCV infection
JG McHutchison, MP Manns, AJ Muir, NA Terrault, IM Jacobson, ...
New England Journal of Medicine 362 (14), 1292-1303, 2010
Thrombocytopenia associated with chronic liver disease
N Afdhal, J McHutchison, R Brown, I Jacobson, M Manns, F Poordad, ...
Journal of hepatology 48 (6), 1000-1007, 2008
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
HS Conjeevaram, MW Fried, LJ Jeffers, NA Terrault, TE Wiley–Lucas, ...
Gastroenterology 131 (2), 470-477, 2006
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial
R Loomba, E Lawitz, PS Mantry, S Jayakumar, SH Caldwell, H Arnold, ...
Hepatology 67 (2), 549-559, 2018
Diagnosis and quantitation of fibrosis
DS Manning, NH Afdhal
Gastroenterology 134 (6), 1670-1681, 2008
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
JG McHutchison, G Dusheiko, ML Shiffman, M Rodriguez-Torres, S Sigal, ...
New England Journal of Medicine 357 (22), 2227-2236, 2007
Helicobacter pylori moves through mucus by reducing mucin viscoelasticity
JP Celli, BS Turner, NH Afdhal, S Keates, I Ghiran, CP Kelly, RH Ewoldt, ...
Proceedings of the National Academy of Sciences 106 (34), 14321-14326, 2009
The natural history of hepatitis C
NH Afdhal
Seminars in liver disease 24 (S 2), 3-8, 2004
IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C
TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ...
Hepatology 52 (6), 1888-1896, 2010
The clinical significance of persistently normal ALT in chronic hepatitis B infection
M Lai, BJ Hyatt, I Nasser, M Curry, NH Afdhal
Journal of hepatology 47 (6), 760-767, 2007
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20